SYNTHESIS OF THE TEDANOLIDES, CYTOTOXIC POLYPROPIONATES
Project Number3R01CA072684-07S1
Contact PI/Project LeaderJUNG, MICHAEL E
Awardee OrganizationUNIVERSITY OF CALIFORNIA LOS ANGELES
Description
Abstract Text
DESCRIPTION: (Applicant's Abstract) The purpose of this proposed research
program is to develop new general methods for the construction of several
biologically active polypropionate natural products. The key step in the
syntheses of these compounds involves a concerted Lewis acid-promoted
rearrangement of an optically active epoxy alcohol to generate a
2-methyl-3-trialkylsilyloxyalkanal, namely an aldol product by a non-aldol
route. We have shown that all four possible enantiomers can be easily prepared
in high optical purity and good yields by this approach. We plan to extend this
research to prepare polypropionate chains with various absolute
stereochemistries. In particular, in order to illustrate the efficiency of this
process, we will finish the synthesis of two extremely strongly cytotoxic
agents, 13-deoxytedanolide 1 and tedanolide 2, and their close structural
analogues, by an application of this new approach to polypropionates.
13-Deoxytedanolide is extremely cytotoxic (IC50 94 pg/ml (P388)) and has high
antitumor activity (T/C 189 percent (P388) at 125 microg/kg) while tedanolide
is also extremely tumor inhibitory (ED50's 250 pg/ml (KB) and 16 pg/ml (PS))
and causes accumulation of cells in the S phase at very low concentrations (10
ng/ml). Thus they are very promising leads as new agents for cancer treatment.
The development of good general routes for their synthesis would not only
provide a potentially useful preparation of them (both were isolated from
marine sponges and are present in very small quantities) but also would allow
one to prepare several structural analogues unavailable from natural sources
which may show enhanced chemotherapeutic properties. We will also carry out
total syntheses of the important antibacterial agents, erythromycin A 3 and
oleandomycin 4. All of the advanced synthetic materials in the tedanolide
series will be tested for antitumor activity. In this way, we hope to figure
out just what parts of these complex molecules are required for the potent
activity and hopefully to prepare some simpler structures which still show
reasonable activity. Likewise the synthetic analogues of erythromycin and
oleandomycin will be tested for antibiotic activity. The successful
accomplishment of the research described in this proposal-namely, the
development of a really useful synthetic route to polypropionates and the
synthesis of the tedanolides, erythromycin A and oleandomycin and their
analogues-would be of great significance to medicinal chemistry. Because of the
medicinal importance of the targets, the efficiency of bond construction in the
syntheses, and the high intrinsic value of the new methods themselves, the
likelihood of an important contribution to health-related science is quite
high.
No Sub Projects information available for 3R01CA072684-07S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01CA072684-07S1
Patents
No Patents information available for 3R01CA072684-07S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01CA072684-07S1
Clinical Studies
No Clinical Studies information available for 3R01CA072684-07S1
News and More
Related News Releases
No news release information available for 3R01CA072684-07S1
History
No Historical information available for 3R01CA072684-07S1
Similar Projects
No Similar Projects information available for 3R01CA072684-07S1